Anti-estrogens come of age: a pioneer looks back.
作者信息
Nelson N J
出版信息
J Natl Cancer Inst. 1998 May 6;90(9):646-7. doi: 10.1093/jnci/90.9.646.
PMID:9586657
Abstract
摘要
相似文献
1
Anti-estrogens come of age: a pioneer looks back.
J Natl Cancer Inst. 1998 May 6;90(9):646-7. doi: 10.1093/jnci/90.9.646.
2
Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow.
J Natl Cancer Inst. 1998 Jul 1;90(13):967-71. doi: 10.1093/jnci/90.13.967.
3
Designer estrogens.
Sci Am. 1998 Oct;279(4):60-7. doi: 10.1038/scientificamerican1098-60.
4
Tamoxifen debate hinges on whose risk is high enough.
J Natl Cancer Inst. 1998 Oct 7;90(19):1428-30. doi: 10.1093/jnci/90.19.1428.
5
Breast Cancer Prevention Trial shows major benefit, some risk.
J Natl Cancer Inst. 1998 May 6;90(9):647-8. doi: 10.1093/jnci/90.9.647.
6
Designer estrogens: breast cancer benefit, remaining questions.
Health News. 1999 Jul 25;5(9):6.
7
One step forward or one step back with tamoxifen?
Lancet. 2000 Sep 9;356(9233):868-9. doi: 10.1016/S0140-6736(00)02670-2.
8
Status of antiestrogen breast cancer prevention trials.
Oncology (Williston Park). 1998 Mar;12(3 Suppl 5):28-31.
9
Breast cancer biology blossoms in the clinic.
Nat Med. 1998 Jul;4(7):761-2. doi: 10.1038/nm0798-761.
10
[Uterine pathology in women with breast cancer treated with tamoxifen].
Pathologica. 1997 Jun;89(3):223-33.
Zotero 插件